Identification of serum amyloid A in the serum of gastric cancer patients by protein expression profiling

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1259-1262

  Liu, Chibo ^a   Pan, Chunqin ^a   Shen, Jianmin ^a   Wang, Haibao ^a   Yong, Liang ^a  

^a TAIZHOU MUNICIPAL HOSPITAL   (China)

Author keywords

Gastric cancer; Serum amyloid a; Surface enhanced laser desorption ionization time of flight mass spectrometry

Indexed keywords

AMYLOID A PROTEIN;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CHINA; CONTROLLED STUDY; CRYSTALLIZATION; DISEASE SEVERITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PREDICTIVE VALUE; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SERUM; STOMACH CARCINOMA; TIME OF FLIGHT MASS SPECTROMETRY;

EID: 84859463492     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.664     Document Type: Article

References (21)

1. Le L, Chi K, Tyldesley S, et al: Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. Clin Chem 51: 695-707, 2005.
2. Yu Y, Chen S, Wang LS, et al: Prediction of pancreatic cancer by serum biomarkers using surface-enhanced laser desorption/ionization-based decision tree classification. Oncology 68: 79-86, 2005.
3. Traub F, Feist H, Kreipe HH and Pich A: SELDI-MS-based expression profiling of ductal invasive and lobular invasive human breast carcinomas. Pathol Res Pract 201: 763-770, 2005.
4. Cho WC and Ngan RK: Biomarker discovery in nasopharyngeal carcinoma using proteinchip profiling. J Hong Kong Coll Radiol 11: 63-68, 2008.
5. Cho WC: Proteomics technologies and challenges. Genomics Proteomics Bioinformatics 5: 77-85, 2007.
6. Sasazuki S, Inoue M, Sawada N, et al: Plasma levels of C-reactive protein and serum amyloid A and gastric cancer in a nested case-control study: Japan Public Health Center-based prospective study. Carcinogenesis 31: 712-718, 2010.
7. Chan DC, Chen CJ, Chu HC, et al: Evaluation of serum amyloid A as a biomarker for gastric cancer. Ann Surg Oncol 14: 84-93, 2007.
8. Cho WC: Research progress in SELDI-TOF-MS and its clinical applications. Sheng Wu Gong Cheng Xue Bao 22: 871-876, 2006.
9. Woong-Shick A, Sung-Pil P, Su-Mi B, et al: Identification of hemoglobin-alpha and -beta subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer. Cancer Sci 96: 197-201, 2005.
10. Liang Y, Fang M, Li J, et al: Serum proteomic patterns for gastric lesions as revealed by SELDI mass spectrometry. Exp Mol Pathol 81: 176-180, 2006.
11. Valle RP, Chavany C, Zhukov TA and Jendoubi M: New approaches for biomarker discovery in lung cancer. Expert Rev Mol Diagn 3: 55-67, 2003.
12. Yokoi K, Shih LC, Kobayashi R, et al: Serum amyloid A as a tumor marker in sera of nude mice with orthotopic human pancreatic cancer and in plasma of patients with pancreatic cancer. Int J Oncol 27: 1361-1369, 2005.
13. Laronga C, Becker S, Watson P, et al: SELDI-TOF serum profiling for prognostic and diagnostic classification of breast cancers. Dis Markers 19: 229-238, 2003.
14. Adam BL, Qu Y, Davis JW, et al: Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res 62: 3609-3614, 2002.
15. Petricoin EF, Ardekani AM, Hitt BA, et al: Use of proteomic patterns in serum to identify ovarian cancer. Lancet 359: 572-577, 2002.
16. Cui JF, Liu YK, Zhou HJ, et al: Screening serum hepatocellular carcinoma-associated proteins by SELDI-based protein spectrum analysis. World J Gastroenterol 14: 1257-1262, 2008.
17. Ge Z, Zhu YL, Zhong X, Yu JK and Zheng S: Discovering differential protein expression caused by CagA-induced ERK pathway activation in AGS cells using the SELDI-ProteinChip platform. World J Gastroenterol 14: 554-562, 2008.
18. Cho WC, Yip TT, Ngan RK, et al: ProteinChip array profiling for identification of disease- and chemotherapy-associated biomarkers of nasopharyngeal carcinoma. Clin Chem 53: 241-250, 2007.
19. Malle E and De Beer FC: Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 26: 427-435, 1996.
20. Kokubun M, Imafuku Y, Okada M, Ohguchi Y, Ashikawa T, Yamada T and Yoshida H: Serum amyloid A (SAA) concentration varies among rheumatoid arthritis patients estimated by SAA/CRP ratio. Clin Chim Acta 360: 92-102, 2005.
21. Weinstein PS, Skinner M, Sipe JD, Lokich JJ, Zamcheck N and Cohen AS: Acute-phase proteins or tumour markers: the role of SAA, SAP, CRP and CEA as indicators of metastasis in a broad spectrum of neoplastic diseases. Scand J Immunol 19: 193-198, 1984.